Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia

Completed · Not applicable

Conditions studied: Complex Endometrial Hyperplasia With Atypia, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer, Stage II Uterine Corpus Cancer

In brief

This pilot clinical trial studies whether obese stage I-II endometrial cancer survivors or patients with atypical hyperplasia (abnormal cells in the lining of the uterus) would go see a weight loss specialist if it was recommended by their cancer doctor. Excess body weight or obesity is one of the most common contributors to (causes of) endometrial cancer. Over two-thirds of women who have survived endometrial cancer are obese. Complications of obesity, such as heart disease are often more dangerous than the cancer itself. A weight loss of even 5-10% of excess body weight is associated with improved health. Often, meeting with a doctor or person who is an expert in weight loss (bariatric specialist) is the best way to lose weight and keep it off. Endometrial cancer survivors or patients with atypical hyperplasia who go see a weight loss specialist recommended by their doctor may be able to achieve a healthier body weight.

Key facts

Study ID

NCT02342730

Run by

Case Comprehensive Cancer Center

People needed

127

Starts

2014-12-17

Expected to finish

2015-05-18

Last updated by the study team

2018-11-19

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women with a history of stage I or II endometrial cancer or a diagnosis of complex atypical hyperplasia
• BMI of at least 30 kg/msq

You may not qualify if…

• Advanced disease (stage III or greater)
• Recurrent or progressive endometrial cancer
• Non endometrioid histology (such as serous uterine cancer or uterine carcinosarcoma)
• History of bariatric surgery for weight loss
• Ongoing medically supervised weight loss (under the care of a physician)
• Poorly controlled psychiatric or medical conditions
• Active second primary malignancy

Where it is running

• Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.